RNAC
Price
$10.68
Change
-$0.78 (-6.81%)
Updated
Jun 27 closing price
Capitalization
276.02M
WINT
Price
$0.45
Change
+$0.08 (+21.62%)
Updated
Jun 27 closing price
Capitalization
1.65M
Interact to see
Advertisement

RNAC vs WINT

Header iconRNAC vs WINT Comparison
Open Charts RNAC vs WINTBanner chart's image
Cartesian Therapeutics
Price$10.68
Change-$0.78 (-6.81%)
Volume$300.63K
Capitalization276.02M
Windtree Therapeutics
Price$0.45
Change+$0.08 (+21.62%)
Volume$1.32M
Capitalization1.65M
RNAC vs WINT Comparison Chart in %
Loading...
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RNAC vs. WINT commentary
Jun 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RNAC is a Hold and WINT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 29, 2025
Stock price -- (RNAC: $10.68 vs. WINT: $0.45)
Brand notoriety: RNAC and WINT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RNAC: 419% vs. WINT: 43%
Market capitalization -- RNAC: $276.02M vs. WINT: $1.65M
RNAC [@Biotechnology] is valued at $276.02M. WINT’s [@Biotechnology] market capitalization is $1.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RNAC’s FA Score shows that 0 FA rating(s) are green whileWINT’s FA Score has 1 green FA rating(s).

  • RNAC’s FA Score: 0 green, 5 red.
  • WINT’s FA Score: 1 green, 4 red.
According to our system of comparison, both RNAC and WINT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RNAC’s TA Score shows that 5 TA indicator(s) are bullish while WINT’s TA Score has 3 bullish TA indicator(s).

  • RNAC’s TA Score: 5 bullish, 4 bearish.
  • WINT’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, RNAC is a better buy in the short-term than WINT.

Price Growth

RNAC (@Biotechnology) experienced а +9.43% price change this week, while WINT (@Biotechnology) price change was -21.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RNAC($276M) has a higher market cap than WINT($1.65M). RNAC has higher P/E ratio than WINT: RNAC (2.00) vs WINT (0.83). RNAC YTD gains are higher at: -40.369 vs. WINT (-97.426). WINT has higher annual earnings (EBITDA): -15.85M vs. RNAC (-83.55M). RNAC has more cash in the bank: 180M vs. WINT (1.17M). WINT has less debt than RNAC: WINT (1.58M) vs RNAC (14.1M). RNAC has higher revenues than WINT: RNAC (34.2M) vs WINT (0).
RNACWINTRNAC / WINT
Capitalization276M1.65M16,768%
EBITDA-83.55M-15.85M527%
Gain YTD-40.369-97.42641%
P/E Ratio2.000.83241%
Revenue34.2M0-
Total Cash180M1.17M15,345%
Total Debt14.1M1.58M893%
FUNDAMENTALS RATINGS
RNAC vs WINT: Fundamental Ratings
RNAC
WINT
OUTLOOK RATING
1..100
896
VALUATION
overvalued / fair valued / undervalued
1..100
99
Overvalued
57
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
6498
P/E GROWTH RATING
1..100
456
SEASONALITY SCORE
1..100
n/a85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

WINT's Valuation (57) in the Biotechnology industry is somewhat better than the same rating for RNAC (99). This means that WINT’s stock grew somewhat faster than RNAC’s over the last 12 months.

WINT's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as RNAC (100). This means that WINT’s stock grew similarly to RNAC’s over the last 12 months.

WINT's SMR Rating (99) in the Biotechnology industry is in the same range as RNAC (100). This means that WINT’s stock grew similarly to RNAC’s over the last 12 months.

RNAC's Price Growth Rating (64) in the Biotechnology industry is somewhat better than the same rating for WINT (98). This means that RNAC’s stock grew somewhat faster than WINT’s over the last 12 months.

WINT's P/E Growth Rating (6) in the Biotechnology industry is somewhat better than the same rating for RNAC (45). This means that WINT’s stock grew somewhat faster than RNAC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
RNACWINT
RSI
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
77%
Aroon
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
RNAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
WINT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NROM0.210.03
+17.97%
Noble Roman's, Inc.
KHNGF221.75N/A
N/A
Kuehne & Nagel International AG
PPASF1.55N/A
N/A
Pick n' Pay Stores Ltd.
SHKLY124.00N/A
N/A
Sinotruk Hong Kong Ltd.
LEAT9.02N/A
-0.01%
Leatt Corp.

RNAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, RNAC has been closely correlated with WINT. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if RNAC jumps, then WINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RNAC
1D Price
Change %
RNAC100%
-6.81%
WINT - RNAC
94%
Closely correlated
+21.49%
NCNA - RNAC
92%
Closely correlated
N/A
NBY - RNAC
91%
Closely correlated
+0.97%
SNPX - RNAC
91%
Closely correlated
+23.37%
SNGX - RNAC
89%
Closely correlated
-0.73%
More

WINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, WINT has been closely correlated with CDTX. These tickers have moved in lockstep 94% of the time. This A.I.-generated data suggests there is a high statistical probability that if WINT jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WINT
1D Price
Change %
WINT100%
+21.49%
CDTX - WINT
94%
Closely correlated
+0.24%
NCNA - WINT
92%
Closely correlated
N/A
SNPX - WINT
92%
Closely correlated
+23.37%
NBY - WINT
92%
Closely correlated
+0.97%
AGEN - WINT
91%
Closely correlated
-3.05%
More